Advertisement
U.S. markets open in 1 hour 57 minutes
  • S&P Futures

    5,306.75
    -1.50 (-0.03%)
     
  • Dow Futures

    40,141.00
    -3.00 (-0.01%)
     
  • Nasdaq Futures

    18,497.25
    -6.50 (-0.04%)
     
  • Russell 2000 Futures

    2,139.80
    +1.40 (+0.07%)
     
  • Crude Oil

    82.45
    +1.10 (+1.35%)
     
  • Gold

    2,232.80
    +20.10 (+0.91%)
     
  • Silver

    24.74
    -0.02 (-0.07%)
     
  • EUR/USD

    1.0797
    -0.0033 (-0.30%)
     
  • 10-Yr Bond

    4.1960
    0.0000 (0.00%)
     
  • Vix

    12.99
    +0.21 (+1.64%)
     
  • GBP/USD

    1.2623
    -0.0015 (-0.12%)
     
  • USD/JPY

    151.3660
    +0.1200 (+0.08%)
     
  • Bitcoin USD

    70,729.30
    +653.69 (+0.93%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,956.52
    +24.54 (+0.31%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

CVS Health, Adapt Pharma Team Up to Discount NARCAN Price

CVS Health CVS and Adapt Pharma recently announced a partnership aimed at making the opioid overdose-reversing drug NARCAN Nasal Spray more reasonably priced for patients without insurance coverage.

NARCAN (naloxone hydrochloride), designed by Adapt Pharma, is the first and only U.S Food and Drug Administration-approved ready-to-use nasal spray for emergency treatment of known or suspected opioid overdoses.

Notably, as per the deal, patients purchasing NARCAN from CVS Pharmacy will get a discount coupon worth $35. This reduces the out of pocket cost by approximately 25%. Moreover, to avoid prescription drug abuse and to increase access of naxalone for patients, CVS Health has managed to eliminate the need of a prescription for naxalone through a standing order from a physician. CVS pharmacy patients will get an access to this life saving drug expectedly by Aug 2016 in 31 states across the U.S.
    
We believe this partnership will drive the top line for the company over the long haul.

CVS HEALTH CORP Price and Consensus

CVS HEALTH CORP Price and Consensus | CVS HEALTH CORP Quote

Meanwhile, the company is reaching out to help patient communities for a safe livelihood through its new programs and services which include drug abuse prevention education, outreach and access to safe medication disposal.

CVS Health’s Recent Initiatives

In this regard, we take a note on the company’s several recent developments in the field of Pharmacies Services. This include the recent launch of a community outreach programs named as pharmacists Teach, which enables local pharmacists to interact with high school students regarding the risks of drug abuse. Additionally, CVS Health has teamed up with The Partnership for Drug-Free Kids which facilitates a safe and environmental-friendly way of disposing unwanted medication.

We also take a note of the recent medication reconciliation program by CVS Health Research Institute last month. Moreover its CVS Pharmacy has opened a mobile pharmacy in Elkview, West Virginia, in response to the severe flooding that devastated the area in late June.

Apart from that, CVS Health’s specialty pharmacy, an integral part within the Pharmacy Services segment has recently been honored with Specialty Pharmacy accreditation from URAC.

Undoubtedly, these recent flow of developments will help CVS Health’s Pharmacy Services to remain on growth track over the longer term.

Zacks Rank and Key Picks

CVS Health currently bears a Zacks Rank #4 (Sell).

Better-ranked stocks in the medical sector are Masimo Corporation MASI, Natus Medical Inc. BABY and Mesa Laboratories Inc. MLAB. All the three companies sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
MASIMO CORP (MASI): Free Stock Analysis Report
 
NATUS MEDICAL (BABY): Free Stock Analysis Report
 
MESA LABS INC (MLAB): Free Stock Analysis Report
 
CVS HEALTH CORP (CVS): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Advertisement